Trials / Unknown
UnknownNCT04019080
Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Karolinska University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives are to determine the clinical profile, determinants of treatment adherence, long-term safety and to describe the patient journey from the first sign of disease to end of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Anti-fibrostic drugs | The real-Life use of anti-fibrotic drugs in patients with idiopathic pulmonary fibrosis in Sweden |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2019-07-15
- Last updated
- 2019-07-15
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04019080. Inclusion in this directory is not an endorsement.